FTI
45
-5
STI
7
-12
L
59
-4
CMS
55
2
MET
64
-2
TRIP
63
2
OI
41
-5
KSS
52
2
PH
67
-3
GD
57
-2
RF
51
-3
HES
53
-6
HCP
49
-3
NWSA
52
3
LYB
46
-5
UPS
43
-2
F
44
-3
TSCO
58
-2
SRE
63
2
LH
36
-4
FTI
45
-5
STI
7
-12
L
59
-4
CMS
55
2
MET
64
-2
TRIP
63
2
OI
41
-5
KSS
52
2
PH
67
-3
GD
57
-2
RF
51
-3
HES
53
-6
HCP
49
-3
NWSA
52
3
LYB
46
-5
UPS
43
-2
F
44
-3
TSCO
58
-2
SRE
63
2
LH
36
-4
Financhill
Back

ProShares UltraShort Nasdaq Biotech Stock Predictions

The truth about AI stocks (must see)

Learn the names of all 10 stocks here. FREE.
Sell
28

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
14.59
Seasonality Move:
-12.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Multimillionaire Trader Reveals His #1 Gold Pick

Click here to learn more about this game-changing opportunity.

ProShares UltraShort Nasdaq Biotech Stock Forecast

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 28.2% based on the past 14 years of stock performance.
  • ProShares UltraShort Nasdaq Biotech has fallen lower in 12 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 85.71%
  • Is ProShares UltraShort Nasdaq Biotech Stock Undervalued?
    The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.89. The Score for BIS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will ProShares UltraShort Nasdaq Biotech Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 28.2% based on the past 14 years of stock performance.

ProShares UltraShort Nasdaq Biotech Stock Rating

Sell
28
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech overpriced?

  • ProShares UltraShort Nasdaq Biotech has fallen lower in 12 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 85.71%

ProShares UltraShort Nasdaq Biotech Stock Price History

Is BIS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
26.51
52-Week Low:
14.05

Prediction Charts

Market Cap:
0
Price in USD:
14.89
Volume:
6.12K
Beta:
-1.68

Technical Analysis

SMA50:
15.10
SMA100:
15.68
SMA200:
16.91
52-Wk Change:
-34.12%

Stock Predictions

  • Is ProShares UltraShort Nasdaq Biotech stock public?
    Yes, ProShares UltraShort Nasdaq Biotech is a publicly traded company.
  • What is the ProShares UltraShort Nasdaq Biotech stock quote today?
    The ProShares UltraShort Nasdaq Biotech stock price is 14.89 USD today.
  • How to buy ProShares UltraShort Nasdaq Biotech stock online?
    You can buy ProShares UltraShort Nasdaq Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-26 15.35 15.27 15.37 15.20
Sep-27 14.97 15.21 15.21 14.97
Sep-30 15.26 15.04 15.34 15.09
Oct-1 15.29 15.22 15.49 15.21
Oct-2 15.48 15.24 15.52 15.21
Oct-3 15.58 15.68 15.70 15.58
Oct-4 15.38 15.45 15.61 15.38
Oct-7 15.50 15.85 15.89 15.50
Oct-8 15.82 15.66 15.82 15.56
Oct-9 15.77 15.59 15.77 15.59
Oct-10 15.78 15.64 15.79 15.60
Oct-11 15.61 15.06 15.61 15.05
Oct-14 15.08 14.98 15.15 14.95
Oct-15 14.94 14.89 14.95 14.80

ProShares UltraShort Nasdaq Biotech Earnings

Data Unavailable

ProShares UltraShort Nasdaq Biotech Forecast Revenue Growth

Data Unavailable

* ProShares UltraShort Nasdaq Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.